Search results (643)
« Back to NewsThe latest updates on our research and how it is improving people’s lives.
Paul Kubes joins the Kennedy Institute as the Newton-Abraham Visiting Professor
9 December 2024
Paul joined the Kennedy Institute in September 2024 as part of the Newton-Abraham Visiting Professorship, a prestigious award given by the University of Oxford to the most distinguished scholars in the biological, chemical or medical sciences.
Machine learning outperforms surgeons in predicting knee replacement outcomes
5 December 2024
A new study has revealed that machine learning models can significantly outperform experienced surgeons in predicting patient outcomes after partial knee replacement.
NDORMS study highlights lingering symptoms long after COVID-19 infection
15 November 2024
A new international study has shed light on the significant burden of post-acute COVID-19 symptoms across N. America, Europe and Asia.
Oxford space lab experiment heads to International Space Station
5 November 2024
The first human tissue samples from Oxford's Space Innovation Lab (SIL) have been launched and are on their way to the International Space Station, where they will be used to study the effects of space microgravity on the human ageing process.
The Oxford EMCRF launches new bone marrow biopsy capability to expand research support
4 November 2024
The NIHR Oxford Clinical Research Facility (EMCRF) has expanded its support of medical research trials by offering bone marrow biopsies for the first time.
New co-directors of the taught MSc in Musculoskeletal Sciences announced
1 November 2024
NDORMS is pleased to announce the appointment of Sarah Snelling and Antony Palmer as the new co-Directors of the two-year, part-time MSc in Musculoskeletal Sciences.
Post-acute infection syndrome is not unique to COVID-19
25 October 2024
Patients hospitalised with COVID-19 often report a wide range of symptoms months after their initial illness. But a new study from NDORMS shows that post-acute infection syndrome (PAIS) is not unique to COVID-19 and can also occur after other respiratory infections.
Cellular roadmap reveals new paths to treating inflammatory bowel disease
22 October 2024
In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.
New MSc course comes to NDORMS
22 October 2024
The MSc in Experimental and Translational Therapeutics (ETT) is moving to NDORMS. Jointly run with the Department of Continuing Education, the move will expand the already broad range of disciplines covered in the course.
World Arthritis Day 2024 - Empowering patients in rheumatology
12 October 2024
To mark World Arthritis Day, the British Society for Rheumatology has announced the launch of a new toolkit that will help patients take more control of their arthritis treatment.
Translational funding enables preclinical trial of new treatment for torn ACL injuries
2 October 2024
NDORMS researchers have received funding from the Medical Research Council (MRC) to explore a new treatment for anterior cruciate ligament (ACL) injuries which could provide relief for thousands of young people suffering from knee pain.
Dr Kate Coldwell awarded Daphne Jackson Fellowship to study links between liver disease and gut bacteria
17 September 2024
Dr Kate Coldwell has joined the Oxford Centre for Microbiome Studies at the Kennedy Institute to study the links between liver disease and gut bacteria, having been awarded the Daphne Jackson Fellowship, co-funded by the Kennedy Trust for Rheumatology Research (KTRR) and the Medical Research Council.
Kennedy scientists honoured with Royal Society Medal
16 September 2024
Professor Sir Ravinder Maini and Professor Sir Marc Feldmann have jointly received The Royal Society’s Royal Medal (Applied) for inventing anti-TNF therapy to treat rheumatoid arthritis (RA), bringing it from bench to bedside in one of the biggest success stories of modern medicine.
NDORMS researchers honoured in the Recognition of Distinction Scheme 2024
4 September 2024
Tal Arnon, Stephanie Dakin and Catherine Swales have each been awarded title of ‘Full Professor’ in the University of Oxford's 2024 Recognition of Distinction exercise.
CRUK funding will help develop new targets for ovarian cancer
21 August 2024
Irina Udalova has received funding from Cancer Research UK (CRUK) to study the diverse role of neutrophils in ovarian cancer.
NDORMS joins the Human Functional Genomics Initiative
19 August 2024
£28.5m in funding has been announced to support functional genomics research across the UK, including a research cluster at NDORMS that will deliver insights into musculoskeletal health and disease.
Healthy lifestyle lowers the risk of post-COVID complications
13 August 2024
A new NDORMS study has found that a healthy lifestyle can significantly reduce the risk of post-COVID complications, hospitalisation, and death.
New donation secures future of Emergency Medicine research at Oxford
7 August 2024
A new research programme in emergency medicine begins today at the University of Oxford following a donation from the Kadoorie Foundation.
New prediction model could help inform patients of their risks of having shoulder replacement surgery
31 July 2024
A new model to predict the risk of serious complications after shoulder replacement surgery has been developed in a collaboration between researchers from the University of Oxford, University of Bristol, and University of Copenhagen. The model could be an important tool to help both patients and doctors make more informed decisions about this common procedure.
The evolving single-cell and spatial technology landscape
17 July 2024
The scTrends consortium has published its first report that sheds light on the current state of the commercial single-cell and spatial genomics industry and its potential impact on drug discovery and patient care.